GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma AS (STU:A71) » Definitions » Pretax Margin %

Ascendis Pharma AS (STU:A71) Pretax Margin % : -21.50% (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Ascendis Pharma AS Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Ascendis Pharma AS's Pre-Tax Income for the three months ended in Dec. 2024 was €-37.4 Mil. Ascendis Pharma AS's Revenue for the three months ended in Dec. 2024 was €173.9 Mil. Therefore, Ascendis Pharma AS's pretax margin for the quarter that ended in Dec. 2024 was -21.50%.

The historical rank and industry rank for Ascendis Pharma AS's Pretax Margin % or its related term are showing as below:

STU:A71' s Pretax Margin % Range Over the Past 10 Years
Min: -8127.44   Med: -1362.67   Max: -102.64
Current: -104.12


STU:A71's Pretax Margin % is ranked better than
51.96% of 995 companies
in the Biotechnology industry
Industry Median: -125.57 vs STU:A71: -104.12

Ascendis Pharma AS Pretax Margin % Historical Data

The historical data trend for Ascendis Pharma AS's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma AS Pretax Margin % Chart

Ascendis Pharma AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6,028.68 -4,936.28 -1,129.12 -177.77 -102.64

Ascendis Pharma AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -58.89 -134.03 -303.21 -169.76 -21.50

Competitive Comparison of Ascendis Pharma AS's Pretax Margin %

For the Biotechnology subindustry, Ascendis Pharma AS's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascendis Pharma AS's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma AS's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma AS's Pretax Margin % falls into.


;
;

Ascendis Pharma AS Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Ascendis Pharma AS's Pretax Margin for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-373.241/363.641
=-102.64 %

Ascendis Pharma AS's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-37.384/173.916
=-21.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ascendis Pharma AS  (STU:A71) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Ascendis Pharma AS Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma AS's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ascendis Pharma AS Business Description

Traded in Other Exchanges
Address
Tuborg Boulevard 12, Hellerup, DNK, DK-2900
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

Ascendis Pharma AS Headlines

No Headlines